Previous 10 | Next 10 |
Abeona Therapeutics ( NASDAQ: ABEO ) received Nasdaq notification informing it has regained compliance with the minimum bid price requirement. The requirement was met on July 18, 2022. For further details see: Abeona therapeutics regains compliance with Nasdaq mi...
NEW YORK and CLEVELAND, July 20, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it received notice from The Nasdaq Stock Market LLC (Nasdaq) on July 19, 2022 informing Abeona that it has regained compliance with the minimum bid price requirement under ...
Gainers: Grove Collaborative ( GROV ) +80% . Faraday Future Intelligent Electric ( FFIE ) +30% . Bed Bath & Beyond ( BBBY ) +27% . Dakota Gold ( DC ) +21% . Bolt Biotherapeutics ( BOLT ) +20% . Miromatrix Medical ( MIRO...
Nano-cap clinical stage biotech Abeona Therapeutics ( NASDAQ: ABEO ) plunged ~21% Tuesday after the company shares began trading on a split-adjusted basis following a 25-to-1 reverse stock split. Last Thursday, Abeona ( ABEO ) disclosed the filing of an amendment t...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time to dive into all of the latest stock market news for Tuesday morning as we go over the biggest pre-market stock movers! We’ve got a reverse stock split, new ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Regis (NYSE: RGS ) stock leads our gainers on a partnership. DocuSign (NASDAQ: DOCU ) stock tops out losers on an earnings report. Clinical trials have several stocks moving today. Source: oneinchpunch...
NEW YORK and CLEVELAND, June 06, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that company management is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9, 2022, at 3:30 p....
Abeona Therapeutics (NASDAQ:ABEO) has been granted additional 180-day by Nasdaq to regain compliance with the $1.00 minimum bid price requirement for continued listing. Common stock continues to trade on the Nasdaq Capital Market under the symbol "ABEO." Nasdaq will provide the company with w...
NEW YORK and CLEVELAND, May 19, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that the Company has been granted an additional 180-day period from Nasdaq’s Listing Qualification Department, through...
Abeona Therapeutics Inc. (ABEO) Q1 2022 Earnings Conference Call May 17, 2022 8:30 am ET Company Participants Vishwas Seshadri - Chief Executive Officer Joseph Vazzano - Chief Financial Officer Brian Kevany - Chief Technical Officer, Head of Research Greg Gin - Vice President, Investor Relati...
News, Short Squeeze, Breakout and More Instantly...
Abeona Therapeutics Inc. Company Name:
ABEO Stock Symbol:
NASDAQ Market:
Abeona Therapeutics Inc. Website:
CLEVELAND and LONDON, July 11, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a cell and gene therapy company with proprietary adeno-associated virus (AAV)-based capsids, and Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, today announced ...
CLEVELAND, July 08, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Abeona’s Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., and Chief Commercial Officer, Madhav Vasanthavada, Ph.D., M.B.A., will participate in a virtual fireside chat at the Sti...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ABEO on July 3, 2024 06:07AM ET. ABEO was trading at $4.12 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...